IV Opioids in the Hospital: A Controversial Lifeline for Patients in Fentanyl Withdrawal
A new viewpoint in the Journal of General Internal Medicine argues that intravenous opioids should be recognized as a legitimate, ...
A new viewpoint in the Journal of General Internal Medicine argues that intravenous opioids should be recognized as a legitimate, ...
A new national analysis finds that medications for alcohol and opioid use disorder reach only a small share of patients, ...
A multi-state analysis of Medicaid claims shows Black and Hispanic patients are significantly less likely to fill and stay on ...
A Stanford-led team trained supervised machine learning models on nationally representative EHR-like survey data to identify people with untreated alcohol, ...
A San Francisco study found that 63 percent of patients given three-day methadone at a low-threshold Bridge Clinic linked to ...
A qualitative study of 28 recently incarcerated adults shows that stigma, transportation, clinic rules and the fentanyl supply shape whether ...
A qualitative study of the Rhode Island Department of Corrections finds that medications for opioid use disorder can reduce contraband ...
New research shows that naltrexone, naloxone, morphine, and fentanyl act as pharmacological chaperones that expand endoplasmic reticulum exit sites and ...
A new review argues that Brixadi, an extended-release injectable buprenorphine approved for opioid use disorder, warrants clinical investigation as a ...
Targeted educational videos featuring a rural physician's experience with buprenorphine significantly reduced perceived barriers and increased primary care practitioners' intention ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine